ASMF Submission Services India

Zymax Pharma provides expert ASMF submission services in India for active pharmaceutical ingredient manufacturers seeking access to the European market. As outlined by the European Medicines Agency's Active Substance Master File procedure , an ASMF allows API manufacturers to protect confidential manufacturing information while still supporting a marketing authorisation application. Our regulatory consultants help Indian API manufacturers prepare, compile, and submit ASMF dossiers that meet EU regulatory expectations.

From Applicant's Part and Restricted Part preparation to eCTD formatting and procedure management, Zymax Pharma supports Indian API manufacturers through every stage of the ASMF submission process for EU, UK, and other ICH-aligned markets.

What is an ASMF?

An Active Substance Master File, commonly abbreviated as ASMF, is a regulatory document that contains detailed confidential information about the manufacturing process, quality controls, and characterisation of an active pharmaceutical ingredient. The ASMF procedure was developed specifically to protect the API manufacturer's proprietary know-how while still allowing the finished product manufacturer, known as the applicant, to submit a complete marketing authorisation dossier.

An ASMF is divided into two parts. The Applicant's Part, also called the Open Part, contains information that the finished product manufacturer needs and can review — including basic manufacturing information, specifications, and stability data summaries. The Restricted Part, also called the Closed Part, contains the full confidential manufacturing details, detailed synthesis route, and proprietary process information that is submitted directly to the regulatory authority by the API manufacturer and is not shared with the applicant.

For Indian API manufacturers supplying the European market, a properly prepared ASMF is essential. Any deficiency in the ASMF can delay or block the marketing authorisation of every finished product that references it — making ASMF quality a direct commercial concern, not just a regulatory formality.

Our ASMF Submission Services in India

Zymax Pharma offers complete ASMF preparation and submission support, covering both the technical content and the regulatory procedure.

• ASMF Dossier Compilation Preparation of both the Applicant's Part and Restricted Part of the ASMF in line with EMA quality guidelines, covering manufacturing process description, control of materials, control of critical steps, and analytical procedures.
• eCTD Formatting and Publishing Conversion of ASMF content into properly structured eCTD format under Module 3.2.S, ensuring correct granularity, bookmarking, hyperlinking, and lifecycle management for electronic submission.
• Quality Overall Summary Support Drafting and review of the Quality Overall Summary sections that reference the ASMF, ensuring consistency between the applicant's dossier and the master file content submitted by the API manufacturer.
• ASMF Procedure Management End-to-end management of the ASMF submission procedure including coordination with the applicant, communication with EU competent authorities, and tracking of submission timelines across multiple member states.
• Deficiency Response and Variation Support Preparation of responses to questions and deficiency letters raised by EU regulatory authorities during ASMF assessment, along with support for ASMF variations following manufacturing changes.
• ASMF to CEP Gap Analysis Comparative assessment for API manufacturers deciding between the ASMF route and the Certificate of Suitability (CEP) route, based on product type, target markets, and existing documentation.

Why ASMF Quality Matters for Indian API Manufacturers

India supplies a significant share of active pharmaceutical ingredients used in finished products sold across Europe. For Indian API manufacturers, the ASMF is often the single most important regulatory document governing their access to the EU market.

A poorly prepared ASMF creates risk not just for the API manufacturer, but for every finished product applicant relying on that master file. Deficiencies in the Restricted Part can delay assessment timelines across multiple simultaneous marketing authorisation applications, damaging commercial relationships and market access for the API supplier.

Zymax Pharma helps Indian API manufacturers prepare ASMF dossiers that are technically robust, internally consistent, and structured to minimise questions from EU assessors — protecting both your regulatory standing and your commercial relationships with finished product customers.

Why Choose Zymax Pharma for ASMF Submission Services

Indian API manufacturers trust Zymax Pharma for ASMF work because of our focused regulatory expertise:

• Specialist understanding of EU ASMF procedure requirements, including worksharing and national procedures.
• Experience preparing both Applicant's Part and Restricted Part content to EMA quality expectations.
• Strong eCTD publishing capability ensuring correct Module 3.2.S structure and lifecycle management.
• Based in Gujarat with close proximity to major Indian API manufacturing clusters.
• Track record supporting deficiency responses and variations across multiple EU member states.
• Clear guidance on choosing between ASMF and CEP routes based on your specific product and market strategy.